Oxford AstraZeneca Vaccine to be Sold to Developing Countries at Cost Price
The coronavirus vaccine produced by Oxford University and AstraZeneca will be available on a non-profit basis “in perpetuity” to low- and middle-income countries in the developing world.
Comments